医学
炎症性肠病
腹泻
血性腹泻
胃肠道
药品
生活质量(医疗保健)
溃疡性结肠炎
内科学
疾病
腹痛
胃肠病学
药物输送
结肠炎
靶向给药
重症监护医学
药理学
化学
有机化学
护理部
作者
Milad Reda Qelliny,Usama Farghaly Aly,Omar H. El-Garhy,Khaled Khaled
出处
期刊:Journal of Advanced Biomedical and Pharmaceutical Sciences
[Egypts Presidential Specialized Council for Education and Scientific Research]
日期:2019-10-01
卷期号:2 (4): 164-184
被引量:12
标识
DOI:10.21608/jabps.2019.14835.1052
摘要
Inflammatory bowel disease (IBD) is one of the most common chronic diseases that affect the entire gastrointestinal tract (GIT) especially the colon. Its symptoms extend from mild diarrhea, abdominal pain, and bloody diarrhea to severe conditions which affect the quality of life. Many treatments have been developed to treat and cure IBD and to improve patient's quality of life. The big challenge faces the newly developed treatments is the site of action as the colon presents at the distal end of the GIT and have a complex biological environment. Many technologies have been investigated to target the colon, load higher amounts of active ingredients, and decrease unwanted side effects resulted from upper GIT absorption. This review briefly discusses the IBD, treatment lines, physiological considerations, and all methods of colon targeting technologies starting from the traditional methods which based on pH, time, and microbial content of the colon. Also, we discussed in detail all new techniques based on Micro and Nanotechnology which improve the effectiveness of used therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI